Overexpressed FOXM1 collaborates with MMB to increase WEE1 inhibitor sensitivity in NSCLC

Jian Tan1, Jingbo Ma1, Weiqiang Zhang1

  • 1Department of Thoracic Surgery, Seventh Medical Center of Chinese PLA General Hospital, Beijing, China.

PubMed
Abstract

Insights

Forkhead box M1 (FOXM1) and MYB-MuvB complex (MMB) interaction enhances sensitivity to WEE1 inhibitors in non-small cell lung cancer (NSCLC). This FOXM1-MMB complex promotes DNA replication stress and activates checkpoints, offering new therapeutic strategies for NSCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Non-small cell lung cancer (NSCLC) presents a significant mortality challenge.
  • The MYB-MuvB (MMB) complex interacting with forkhead box M1 (FOXM1) is crucial for cell cycle progression.
  • The precise role of the FOXM1-MMB complex in WEE1 inhibitor sensitivity within NSCLC remains largely undetermined.

Purpose of the Study:

  • To elucidate the role of the FOXM1-MMB complex in modulating WEE1 inhibitor sensitivity in NSCLC.
  • To investigate how FOXM1 affects DNA replication stress, DNA damage, and cell cycle checkpoints in response to WEE1 inhibition.
  • To determine the therapeutic implications of targeting the FOXM1-MMB complex in NSCLC treatment.

Main Methods:

  • Quantitative polymerase chain reaction (RT-qPCR) to assess mRNA levels of FOXM1, LIN54, RPA, γH2AX, and CCNB.
  • Western blotting to evaluate corresponding protein expression levels.
  • Cell Counting Kit-8 (CCK-8) assay to determine cell viability and response to AZD-1775 treatment.

Main Results:

  • FOXM1 overexpression significantly decreased cell survival under WEE1 inhibition, an effect reversed by LIN54 knockdown, confirming the necessity of the FOXM1-MMB complex.
  • FOXM1 upregulation intensified DNA replication stress and DNA damage, evidenced by increased RPA and γH2AX expression.
  • The FOXM1-MMB complex was shown to activate G2/M checkpoints by enhancing CCNB expression and promoting WEE1 dephosphorylation, thereby increasing sensitivity to the WEE1 inhibitor AZD-1775.

Conclusions:

  • Overexpressed FOXM1, in conjunction with the MMB complex, enhances WEE1 inhibitor sensitivity in NSCLC.
  • The FOXM1-MMB complex plays a critical regulatory role in NSCLC pathogenesis and response to targeted therapies.
  • Targeting the FOXM1-MMB pathway presents a promising therapeutic strategy for NSCLC patients.

Related Concept Videos

Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...